News & Updates

Treatment with semaglutide can significantly lower the risk of time to first heart failure (HF) events or cardiovascular (CV) death in type 2 diabetes (T2D) patients with chronic kidney disease (CKD), a recent study has shown.

For patients with breast cancer undergoing adjuvant radiotherapy, statin therapy appears to confer cardioprotective effects, mitigating the risk of major adverse cardiovascular event, according to a retrospective study.